Araris Biotech
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
3
Funding Rounds
$33.5m
Money raised
Overview
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Is****** At************* |
|
- | - |
| Ph***** Sp***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Araris Biotech has raised a total of $19.5m in funding over 3 rounds.
Key Insights:
- Araris Biotech October 2020 Seed Funding Round: $17m
- Araris Biotech Seed round, August 2019: $2.5m
- Araris Biotech Seed round October 2020: $14m
Araris Biotech October 2020 Seed Funding Round
$17m
Araris Biotech Seed round, August 2019
$2.5m
Araris Biotech Seed round October 2020
$14m
Industries
Araris Biotech is active in the following industries: